FDA: ANSAID wasn't pulled for safety, so it's still here.
The federal government confirmed that ANSAID, a common nonsteroidal anti-inflammatory drug, was not withdrawn from the market for safety or effectiveness reasons, keeping a familiar name in your medicine cabinet.
By Foodie Pundit Newsroom - Published - Updated - Section: Health Nutrition
Key points
- The FDA has determined that ANSAID tablets were not withdrawn from the market for reasons of safety or effectiveness.
- This decision allows for the continued approval and sale of generic versions of flurbiprofen, the active ingredient in ANSAID.
- The primary beneficiaries are generic drug manufacturers, who can now more easily bring their products to market.
- The FDA is the agency with the authority to make this determination, which is a standard part of its drug regulation process.
- This ruling ensures that a lower-cost option for an established anti-inflammatory drug remains available to consumers.
This report is part of Foodie Pundit premium coverage. Foodie Pundit members read the full story. See membership.
More from the Foodie Pundit Newsroom
- The New Anti-Aging Diet for Your Brain
- The USDA Is Paying Titan Peach Farms Millions For Your Food
- Low Effort Grazing Culture Proves Its Staying Power as Girl Dinner Becomes Permanent Dining Habit
- Viral Demand Drives Interest in New Cosmic Soft Serve Menu Items
- Kremers Urban Is Fighting the FDA To Keep Its ADHD Drug on the Market